Literature DB >> 7361734

Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale with failure of the right side of the heart.

R C Stern, G Borkat, S S Hirschfeld, T F Boat, L W Matthews, J Liebman, C F Doershuk.   

Abstract

Failure of the right side of the heart with cardiac dilation and fluid retention occurred in 55 of 170 patients who died of cystic fibrosis; six patients survive. All had severe hypoxia, but 24% had normal PaCO2. Cardiac catheterization showed high mean pulmonary artery pressure and resistance. Pulmonary artery wedge pressure was greater than 12 mm Hg in 40% of the patients. Mean survival was eight months. Male survival was significantly better than female survival. Digitalis treatment was of no clear benefit. Tolazoline hydrochloride was also ineffective. Recent medical advances have not substantially affected prognosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361734     DOI: 10.1001/archpedi.1980.02130150025007

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  13 in total

Review 1.  The heart in cystic fibrosis.

Authors:  Rowland J Bright-Thomas; A Kevin Webb
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Ischaemic heart disease--a new issue in cystic fibrosis?

Authors:  Felicity M R Perrin; Walter Serino
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

Review 3.  Cor pulmonale in cystic fibrosis.

Authors:  M H Götz; O C Burghuber; U Salzer-Muhar; W Wolosczuk; M Weissel; E Hartter
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

4.  Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI.

Authors:  Sebastian Ley; Michael Puderbach; Christian Fink; Monika Eichinger; Christian Plathow; Susanne Teiner; Matthias Wiebel; Frank-Michael Müller; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2005-03-11       Impact factor: 5.315

5.  Acute effects on pulmonary haemodynamics of nifedipine in adult patients with cystic fibrosis.

Authors:  I Eichler; O C Burghuber; M Götz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis.

Authors:  Don Hayes; Curt J Daniels; Stephen Kirkby; Benjamin T Kopp; Kerri L Nicholson; Ashley E Nance; Mark L Splaingard
Journal:  Lung       Date:  2014-03-27       Impact factor: 2.584

7.  Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.

Authors:  Molly K Ball; Gregory B Waypa; Paul T Mungai; Jacqueline M Nielsen; Lyubov Czech; V Joseph Dudley; Lauren Beussink; Robert W Dettman; Sara K Berkelhamer; Robin H Steinhorn; Sanjiv J Shah; Paul T Schumacker
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

Review 8.  Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Authors:  Adriano R Tonelli
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

9.  Heart-lung transplantation for cystic fibrosis. 1: Assessment.

Authors:  B Whitehead; P Helms; M Goodwin; I Martin; B Lask; E Serrano; J P Scott; R L Smyth; T W Higenbottam; J Wallwork
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

10.  Lower extremity edema and pulmonary hypertension in morbidly obese patients with obstructive sleep apnea.

Authors:  Daniel J O'Hearn; Avram R Gold; Morris S Gold; Paul Diggs; Steven M Scharf
Journal:  Sleep Breath       Date:  2008-07-10       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.